Valuation : 3SBio Inc.

Market Cap 32.92B 38.48B 4.91B 4.23B 4B 3.63B 6.81B 469B 6.84B 47.54B 18.28B 238B 18.43B 18.02B 754B P/E 2026 *
14x
P/E 2027 * 12.9x
Enterprise Value 22.34B 26.11B 3.33B 2.87B 2.72B 2.46B 4.62B 318B 4.64B 32.26B 12.41B 162B 12.5B 12.23B 511B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 1.93x
Free-Float
74.7%
Yield 2026 *
1.56%
Yield 2027 * 1.92%
1 day-0.64%
1 week-4.93%
Current month-4.22%
1 month-12.37%
3 months-6.82%
6 months-27.31%
Current year-36.15%
1 week 15.1
Extreme 15.1
16.63
1 month 15.1
Extreme 15.1
18.65
Current year 14.81
Extreme 14.81
29.3
1 year 14.81
Extreme 14.81
35.42
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2006
Director of Finance/CFO 43 03/07/2023
Corporate Officer/Principal 56 27/11/2014
Director TitleAgeSince
Chairman 63 03/04/2012
Director/Board Member 56 11/06/2012
Director/Board Member 57 01/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
9/7/26 A Other

Chief Executive Officer

490,000 0.0193%
7/29/25 A Other

Chief Executive Officer

440,000 0.0184%
4/15/25 A Other

Director

26,000 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%-4.93%-52.55%+120.89% 4.91B
-1.48%-5.59%+39.55%-6.16% 78.04B
+5.38%-1.09%+512.38%+36.80% 57.48B
-1.42%-4.24%-19.59%-38.20% 57.4B
-0.56%-2.21%-11.34%+27.29% 48.81B
+1.93%-2.37%-0.87%+149.45% 45.5B
+0.80%-1.67%+49.90%-15.98% 32.08B
-1.47%-4.17%+46.17%+89.12% 24.62B
-0.85%-8.64%-4.39%+161.31% 20.77B
-0.09%-3.61%+62.49%+98.37% 15.75B
Average +0.16%-3.98%+62.18%+62.29% 38.53B
Weighted average by Cap. +0.36%-3.73%+88.73%+38.27%

Financials

2026 *2027 *
Net sales 9.38B 10.96B 1.4B 1.2B 1.14B 1.03B 1.94B 134B 1.95B 13.54B 5.21B 67.93B 5.25B 5.13B 215B 10.01B 11.71B 1.49B 1.29B 1.22B 1.1B 2.07B 143B 2.08B 14.46B 5.56B 72.54B 5.61B 5.48B 229B
Net income 2.34B 2.74B 349M 301M 285M 258M 484M 33.32B 486M 3.38B 1.3B 16.95B 1.31B 1.28B 53.57B 2.63B 3.07B 392M 338M 320M 290M 544M 37.45B 547M 3.8B 1.46B 19.05B 1.47B 1.44B 60.21B
Net Debt -10.58B -12.37B -1.58B -1.36B -1.29B -1.17B -2.19B -151B -2.2B -15.28B -5.88B -76.64B -5.92B -5.79B -242B -13.55B -15.84B -2.02B -1.74B -1.65B -1.49B -2.8B -193B -2.82B -19.57B -7.52B -98.16B -7.58B -7.42B -310B
Logo 3SBio Inc.
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,068
Date Price Change Volume
11/09/26 HK$15.44 -0.64% 19,171,711
10/09/26 HK$15.54 -3.78% 35,811,208
09/09/26 HK$16.15 -1.70% 16,834,177
08/09/26 HK$16.43 +2.43% 15,426,469
07/09/26 HK$16.04 -1.23% 9,889,784
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
13.21CNY
Average target price
26.68CNY
Spread / Average Target
+101.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1530 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!